Baystate Wealth Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$111K Buy
+1,103
New +$109K 0.01% 261
2023
Q3
Hold
0
1011
2023
Q2
Sell
-2,094
Closed -$177K 1031
2023
Q1
$158K Buy
2,094
+26
+1% +$1.96K 0.01% 203
2022
Q4
$159K Buy
2,068
+15
+0.7% +$1.14K 0.01% 210
2022
Q3
$137K Buy
2,053
+19
+0.9% +$1.2K 0.01% 202
2022
Q2
$106K Buy
2,034
+16
+0.8% +$909 0.01% 229
2022
Q1
$114K Buy
2,018
+18
+0.9% +$964 0.01% 229
2021
Q4
$103K Buy
+2,000
New +$98.1K 0.01% 240

Other funds holding CAH

Baystate Wealth Management's CAH Position: Q4 2023 in Review

Baystate Wealth Management opened a new position in Cardinal Health (CAH) in Q4 2023: 1,103 shares worth $111K. The stake represents 0.01% of the portfolio and ranks #261 among its holdings. This is a return to the name: Baystate Wealth Management previously reported a position in CAH as recently as Q1 2023.

Baystate Wealth Management first reported a position in CAH in Q4 2021 and has held it in 7 quarters since. The position peaked at $159K in Q4 2022. 1,037 funds tracked by Wall St. Rank hold CAH as of Q4 2023.

  • Baystate Wealth Management held 1,103 shares of Cardinal Health worth $111K as of Q4 2023.
  • Cardinal Health was a new Baystate Wealth Management position in Q4 2023.
  • Cardinal Health made up 0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #261 holding.
  • Baystate Wealth Management first reported a position in Cardinal Health in Q4 2021 and has held it in 7 quarters since.
  • Baystate Wealth Management's Cardinal Health position peaked at $159K in Q4 2022.
  • 1,037 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.